Beth Israel Deaconess Med Ctr; Neurology/MS Center

Boston, Massachusetts 02215

0 studies enrolling now · 3 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting, Non-Small Cell Lung Cancer, Solid Tumors

Studies at this site

• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed
• A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC) — Completed
• Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors — Completed